Philips launched Rapid Equipment Deployment Kit to COVID-19 response
On Aug. 13, 2020, Royal Philips introduced its Rapid Equipment Deployment Kit for ICU ramp-ups, allowing doctors, nurses,…
Dynavax announced grant to scale up CpG 1018 adjuvant capacity to support global COVID-19 response
On Aug. 13, 2020, Dynavax Technologies announced a grant from the Bill & Melinda Gates Foundation of $3.4…
Novavax and SK bioscience announced collaboration for Novavaxﾒ COVID-19 vaccine candidate
On Aug. 13, 2020, Novavax and SK bioscience announced a development and supply agreement for the antigen component…
Heat Biologics’ COVID-19 vaccine demonstrated robust T cell driven immune response to SARS-CoV-2 in preclinical studies
On Aug. 13, 2020, Heat Biologics reported preclinical data for Heat’s gp96-based COVID-19. The data, generated at the…
HHS announced collaboration with Aegis Sciences for high quality rapid COVID-19 RT-PCR testing
On Aug. 13, 2020, the U.S. Department of Health and Human Services (HHS) announced combined investments of $6.5…
Baxter obtained FDA Emergency Use Authorizations for HF20 set and ST set used in CRRT during Covid-19 pandemic
On Aug. 12, 2020, Baxter announced it had received Emergency Use Authorizations (EUAs) from the FDA for the…
FDA approved targeted treatment for rare Duchenne Muscular Dystrophy mutation
On Aug. 12, 2020, the FDA granted accelerated approval to NS Pharma’s Viltepso (viltolarsen) injection for the treatment…
Thermo Fisher Scientific supported COVID-19 testing at historically black colleges and universities seeking a safe return to campus
On Aug. 12, 2020, Thermo Fisher Scientific announced it had committed to supporting the efforts of historically black…
Celdara Medical announced receipt of NIH funding for pandemic influenza antiviral development
On Aug. 12, 2020, Celdara Medical announced that the NIH had awarded a Small Business Innovation Research (SBIR)…
Pfizer and BioNTech announced publication of peer-reviewed data from phase 1/2 study of mRNA-based vaccine candidate
On Aug. 12, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development…
Biotechnology | Disease | HIV | Life Science News | Medicine | Therapeutics | Vaccine
China National Medical Products Administration approved Truvada for HIV pre-exposure prophylaxis
On Aug. 11, 2020, Gilead Sciences announced that the China National Medical Products Administration (NMPA) had approved a…
Hologic launched validated pooling protocol for COVID-19 testing
On Aug. 11, 2020, Hologic announced that it has validated use of its Aptimaﾮ and Panther Fusionﾮ molecular…
Moderna announced supply agreement with US Government for initial 100 million doses of mRNA vaccine against COVID-19
On Aug. 11, 2020, Moderna announced that the U.S. government has secured 100 million doses of mRNA-1273. The…
Bio-Techne announced new SARS-CoV-1/2 spike RBD LlaMABodyﾙ recombinant antibody that blocks viral entry
On Aug. 11, 2020, Bio-Techne announced the release of the SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody, which binds…
LabCorp to perform antibody test at no charge to accelerate COVID-19 blood plasma donation
On Aug. 11, 2020, LabCorpﾮ announced details of a no charge antibody testing program in response to federal…
Clinical trials of monoclonal antibodies to prevent COVID-19 began enrollment
On Aug. 10, 2020, two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs)…
25-year dolphin study revealed factors contributing to aging rates in long-lived mammals
On Aug. 10, 2020, Epitracker and the Translational Genomics Research Institute (TGen) announced the results from a groundbreaking,…
Gilead submited New Drug Application to FDA for Veklury (Remdesivir) for treatment of COVID-19
On Aug. 10, 2020, Gilead Sciences announced that it had submitted a New Drug Application (NDA) to the…
Vaxart announced IND filed for COVID-19 vaccine
On Aug. 10, 2020, Vaxart announced that its COVID-19 Investigational New Drug (IND) application has been filed with…
Cors Blood Registry by Generate Life Sciences partnered with Nantwest to develop COVID-19 treatment
On Aug. 10, 2020, CBRﾮ by Generate Life Sciences, the worldﾒs largest private newborn stem cell bank, and…
Humanigen expands phase III study of lenzilumab in COVID-19 to Brazil
On Aug. 10, 2020, Humanigen announced that the Brazilian regulatory agency, Anvisa, had granted permission to commence a…
IBIO-201 demonstrated ability to elicit anti-SARS-CoV-2 immune response in preclinical studies
On Aug. 10, 2020, iBio provided an update on one of its proprietary vaccine candidates being designed to…
Omeros reported recovery and durvival of all patients in study evaluating narsoplimab fortreatment of COVID-19-associated Acute Respiratory Distress Syndrome
On Aug. 10, 2020, Omeros reported the results of a compassionate-use study evaluating narsoplimab, Omerosﾒ investigational human monoclonal…
Intravacc received US NIH/NIAID contract to develop Enterovirus D68 Vaccine
On Aug. 9, 2020, Intravacc announced that it had been awarded a contract with base and options that…
OpGen began co-marketing COVID-19 antibody test kit
On Aug. 9, 2020, OpGen announced that it had commenced marketing and promotion, on a non-exclusive basis, of…
FDA approved oral treatment for spinal muscular atrophy
On Aug. 7, 2020, the U.S. Food and Drug Administration (FDA) approved Genentech’s Evrysdi (risdiplam) to treat patients…
Scientists revealed structural details of spike protein used in leading COVID-19 vaccine
On Aug. 7, 2020, scientists at Scripps Research announced they had obtained high-resolution, atomic-scale details of the structure…
Altimmune Completed enrollment in phase 1b clinical trial of NasoShield, a single dose intranasal anthrax vaccine candidate
On Aug. 7, 2020, Altimmune announced that it had completed enrollment in its Phase 1b clinical trial of…
Novavax and Takeda announced collaboration for Novavax COVID-19 vaccine candidate in Japan
On Aug. 7, 2020, Novavax and Takeda Pharmaceutical announced a partnership for the development, manufacturing and commercialization of…
Pfizer announced agreement with Gilead to manufacture remdesivir for treatment of COVID-19
On Aug. 7, 2020, Pfizer announced a multi-year agreement with Gilead Sciences to manufacture and supply Gileadﾒs investigational…